Zebrafish offers skin cancer cluesApril 6th, 2011 - 2:53 pm ICT by ANI
London, Apr 6 (ANI): Zebrafish has offered new hope to people with melanoma, an aggressive form of skin cancer.
Researchers identified SETDB1 as a new gene that promotes the growth of melanoma and may play a role in up to 70 percent of malignant melanomas.
“We hope our discovery will ultimately lead to better therapeutic strategies for patients with melanoma,” says study co-first author Yariv J. Houvras, assistant professor of medicine in the Departments of Surgery, Medicine, and Cell and Developmental Biology at Weill Cornell Medical College.
Houvras and colleagues created “MiniCoopR,” a transposon-based vector to deliver candidate human test genes into a specially engineered strain of zebrafish that harbors a mutated BRAF gene. The researchers screened more than 3,000 zebrafish and found one gene that dramatically accelerated melanoma formation: SETDB1, which encodes a histone methyltransferase enzyme. Fish melanomas with elevated levels of SETDB1 are highly invasive and have a set of deregulated genes that are present in human tumors with high levels of SETDB1.
The discovery that SETDB1 accelerates melanoma formation in zebrafish is important because SETDB1 appears to be frequently overexpressed in human melanomas. “SETDB1 is an enzyme, so it may be a good drug target,” explains Houvras. In a second report led by first author Richard White, researchers found that the combination of leflunomide, a drug used to treat arthritis, and a BRAF inhibitor in clinical development was effective in blocking the formation of stem cells in zebrafish that give rise to melanoma.
Houvras explains that the zebrafish is becoming a popular method for investigating malignancies, including melanoma, leukemia and sarcoma.
The study was published in the journal Nature. (ANI)
- Zebrafish model reveals skin cancer-promoting gene - Mar 24, 2011
- Major breakthrough could lead to new treatments for melanoma - Dec 23, 2010
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- 'Penicillin' breakthrough in cancer treatment? - Sep 15, 2010
- New hope in the fight against melanoma - Dec 14, 2010
- Pill to fight deadly skin cancer in sight - Jan 20, 2011
- California scientists hail 'penicillin moment' in cancer treatment - Sep 15, 2010
- Biomarker test shows promise for diagnosis of melanoma - Jan 25, 2011
- DNA that may contribute to each person's uniqueness identified - Aug 12, 2010
- 'Jumping genes' make up roughly half of the human genome - Jun 25, 2010
- Skin cancer pill shrinks tumour in 80 percent cases - Aug 26, 2010
- Skin cancer pill showing 'remarkable' results, say researchers - Aug 26, 2010
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
- New role for zebrafish in human studies - May 20, 2010
Tags: assistant professor, author richard, braf, cancer clues, cancer researchers, cornell medical college, developmental biology, drug target, histone, human test, human tumors, journal nature, malignancies, malignant melanomas, melanoma, new hope, skin cancer, stem cells, therapeutic strategies, weill cornell medical college